Search

everythinglearnresearchcommunity

for

Search:↓

Excessive hair growth is much more common in Chinese women with PCOS than in the general population.

Hirsute women with ovarian-sourced hirsutism are more likely to have irregular periods, with higher BMI and altered hormone ratios.

Certain medications including flutamide, spironolactone, and others effectively reduce excessive hair growth in women, especially when combined with lifestyle changes.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

Spironolactone is more effective than finasteride in treating excessive hair growth in women.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Spironolactone reduces the enzyme activity that converts testosterone to DHT, helping treat excessive hair growth in women.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Finasteride reduces prostate cancer risk by 30% without affecting Gleason scores.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

A simplified scoring system can effectively diagnose hirsutism in Chinese women of reproductive age.

Higher androgen levels are linked to more severe hair growth in hirsute women.

Hirsutism moderately affects the quality of life for most women, linked to condition severity.

Upadacitinib improved multiple immune-related conditions in one patient.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Use good lighting, consistent positioning, and proper camera settings for effective hair disorder photos.

Women with PCOS have lower amylin levels, which are not related to their body weight.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

Dovobet ointment used overnight effectively reduces scalp psoriasis severity and itch.